Cargando…

Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles

A series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give t...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad, Zeinab A., Edrees, Mastoura M., Faty, Rasha A. M., Gomha, Sobhi M., Alterary, Seham S., Mabkhot, Yahia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152077/
https://www.ncbi.nlm.nih.gov/pubmed/28726760
http://dx.doi.org/10.3390/molecules22071211
_version_ 1783357290290610176
author Muhammad, Zeinab A.
Edrees, Mastoura M.
Faty, Rasha A. M.
Gomha, Sobhi M.
Alterary, Seham S.
Mabkhot, Yahia N.
author_facet Muhammad, Zeinab A.
Edrees, Mastoura M.
Faty, Rasha A. M.
Gomha, Sobhi M.
Alterary, Seham S.
Mabkhot, Yahia N.
author_sort Muhammad, Zeinab A.
collection PubMed
description A series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give the corresponding pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones. The assigned structures for all the newly synthesized compounds were confirmed on the basis of elemental analyses and spectral data and the mechanisms of their formation were also discussed. Most of the synthesized compounds were tested for in vitro activity against human lung cancer (A-549) and human hepatocellular carcinoma (HepG-2) cell lines compared with the employed standard antitumor drug (cisplatin) and the results revealed that compounds 8, 4e and 7b have promising activities against the A-549 cell line (IC(50) values of 2.78 ± 0.86 μg/mL, 5.37 ± 0.95 μg/mL and 5.70 ± 0.91 μg/mL, respectively) while compound 7b has promising activity against the HepG-2 cell lines (IC(50) = 3.54 ± 1.11 μg/mL). Moreover, computational studies using MOE 2014.09 software supported the biological activity results.
format Online
Article
Text
id pubmed-6152077
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61520772018-11-13 Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles Muhammad, Zeinab A. Edrees, Mastoura M. Faty, Rasha A. M. Gomha, Sobhi M. Alterary, Seham S. Mabkhot, Yahia N. Molecules Article A series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give the corresponding pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones. The assigned structures for all the newly synthesized compounds were confirmed on the basis of elemental analyses and spectral data and the mechanisms of their formation were also discussed. Most of the synthesized compounds were tested for in vitro activity against human lung cancer (A-549) and human hepatocellular carcinoma (HepG-2) cell lines compared with the employed standard antitumor drug (cisplatin) and the results revealed that compounds 8, 4e and 7b have promising activities against the A-549 cell line (IC(50) values of 2.78 ± 0.86 μg/mL, 5.37 ± 0.95 μg/mL and 5.70 ± 0.91 μg/mL, respectively) while compound 7b has promising activity against the HepG-2 cell lines (IC(50) = 3.54 ± 1.11 μg/mL). Moreover, computational studies using MOE 2014.09 software supported the biological activity results. MDPI 2017-07-20 /pmc/articles/PMC6152077/ /pubmed/28726760 http://dx.doi.org/10.3390/molecules22071211 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Muhammad, Zeinab A.
Edrees, Mastoura M.
Faty, Rasha A. M.
Gomha, Sobhi M.
Alterary, Seham S.
Mabkhot, Yahia N.
Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_full Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_fullStr Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_full_unstemmed Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_short Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_sort synthesis, antitumor evaluation and molecular docking of new morpholine based heterocycles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152077/
https://www.ncbi.nlm.nih.gov/pubmed/28726760
http://dx.doi.org/10.3390/molecules22071211
work_keys_str_mv AT muhammadzeinaba synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT edreesmastouram synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT fatyrashaam synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT gomhasobhim synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT alterarysehams synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT mabkhotyahian synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles